Literature DB >> 18376002

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

B Greg Brown, Allen J Taylor.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18376002     DOI: 10.1056/NEJMe0801608

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

Review 1.  Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Authors:  Michael H Davidson
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

2.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  Michael Clearfield
Journal:  Curr Atheroscler Rep       Date:  2009-01       Impact factor: 5.113

3.  Simvastatin with or without ezetimibe in familial hypercholesterolemia (the ENHANCE trial).

Authors:  John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

4.  Late-breaking trials at the ACC scientific sessions: insights and controversy.

Authors:  Steven E Nissen
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

5.  Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.

Authors:  Brian Godman; Ulrich Schwabe; Gisbert Selke; Björn Wettermark
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Assessment of new technologies: surrogate endpoints versus outcomes, and the cost of health care.

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

Review 7.  Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugs.

Authors:  Peter P Toth
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

8.  Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.

Authors:  Philip Schwab; Anthony Louder; Yong Li; Rajiv Mallick; Harold Bays
Journal:  Drugs Aging       Date:  2014-09       Impact factor: 3.923

9.  Identification of novel inhibitors of dietary lipid absorption using zebrafish.

Authors:  Justin D Clifton; Edinson Lucumi; Michael C Myers; Andrew Napper; Kotaro Hama; Steven A Farber; Amos B Smith; Donna M Huryn; Scott L Diamond; Michael Pack
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

10.  Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

Authors:  Venkatesh Mani; Paul Muntner; Samuel S Gidding; Silvia H Aguiar; Hamza El Aidi; Karen B Weinshelbaum; Hiroaki Taniguchi; Rob van der Geest; Johan H C Reiber; Sameer Bansilal; Michael Farkouh; Valentin Fuster; John E Postley; Mark Woodward; Zahi A Fayad
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-24       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.